Sort
85,873 grants matching “alzheimers”
Stalled capillary flow: a novel mechanism for hypoperfusion in Alzheimer disease
$2,293,767Chris B Schaffer · Cornell University · RF1 · FY2021 · AG
Genetic Epidemiology and Multi-Omics Analyses in Familial and Sporadic Alzheimer's Disease Among Secular Caribbean Hispanics and Religious Order
$2,293,547Richard Mayeux · Columbia University Health Sciences · R01 · FY2021 · AG
Traffic-related air pollution exacerbates AD-relevant phenotypes in a genetically susceptible rat model via neuroinflammatory mechanism(s)
$2,293,425Pamela J Lein · University Of California At Davis · RF1 · FY2021 · AG
Functional Genomics and Bioinformatics Data management Core
$2,293,280Seyed Ali Mortazavi · University Of California-Irvine · U54 · FY2023 · AG
Functional Genomics and Bioinformatics Data management Core
$2,293,280Seyed Ali Mortazavi · University Of California-Irvine · U54 · FY2024 · AG
African Ancestry and the Genomic Architecture of AD and Other Common Neurodegenerative Disease Neuropathologies
$2,292,833David A Bennett · Rush University Medical Center · R01 · FY2022 · AG
Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial of T3D-959 in Mild to Moderate Alzheimer's Disease Subjects
$2,292,799John Didsbury · T3d Therapeutics, Inc. · R01 · FY2019 · AG
Deconvoluting Redox Biology with Targeted Chemistry
$2,292,671Yimon Aye · Cornell University · DP2 · FY2014 · GM
Clinical trials to prevent Alzheimer's Disease in Down Syndrome
$2,292,447Michael S Rafii · University Of Southern California · R33 · FY2022 · AG
Disease Model Development and Phenotyping Project
$2,291,919Gareth R Howell · Indiana University Indianapolis · U54 · FY2017 · AG
Impact of Intensive Treatment of Systolic Blood Pressure on Brain Perfusion, Amyloid and Tau in Older Adults (IPAT-study)
$2,291,354Rong Zhang · Ut Southwestern Medical Center · R01 · FY2023 · AG
Machine Learning and Large-scale Imaging analytics for dimensional representations of brain trajectories in aging and preclinical Alzheimer's Disease: The brain aging chart and the iSTAGING consortium
$2,290,964Christos Davatzikos · University Of Pennsylvania · RF1 · FY2022 · AG
Genomic, Epigenomic, and Transcriptomic Mechanisms of Contributing to Alzheimer's Disease Risk in Diverse Ancestral Populations
$2,290,195Anthony John Griswold · University Of Miami School Of Medicine · RF1 · FY2021 · AG
Amyloidosis associated proteins in Alzheimerâs disease pathogenesis
$2,290,100Stefan Prokop · University Of Florida · RF1 · FY2021 · AG
A Proof of Concept Study Examining The Safety and Efficacy of Innate Immune Syste
$2,289,628Owen Hagino · Sanofi Aventis U S, Inc. · UF1 · FY2013 · AG
Brain metabolism during task-evoked and spontaneous activity in aging and Alzheimer's disease
$2,289,625Andrei G. Vlassenko · Washington University · RF1 · FY2023 · AG
Air pollution, the social environment, and Alzheimer's disease: Risk and resilience in the Ginkgo Evaluation Memory Study
$2,288,624Joel Daniel Kaufman · University Of Washington · RF1 · FY2017 · AG
Mild Cognitive Impairment and Alzheimer's Disease and Related Dementias: Cross-national longitudinal prognosis and risk factors
$2,288,528Miguel Arce · Columbia University Health Sciences · RF1 · FY2024 · AG
ALZHEIMERS DISEASE RESEARCH CENTER
$2,288,492Mount Sinai School Of Medicine Of Nyu · P50 · FY2003 · AG
Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA.
$2,288,273Michael G Agadjanyan · Institute For Molecular Medicine · R01 · FY2025 · AG
DATA CORE (DC)
$2,288,186Ronald G. Thomas · University Of California, San Diego · U01 · FY2008 · AG
White Matter Metabolism in the Context of Aging, White Matter Hyperintensities and Alzheimer's Disease
$2,287,856Andrei G. Vlassenko · Washington University · RF1 · FY2022 · AG
Antecedent Biomarkers For AD: The Adult Children Study
$2,287,585John Morris · Washington University · P01 · FY2015 · AG
HIGH-SENSITIVITY NMR AT ROOM TEMPERATURE FOR MOLECULAR STRUCTURE AND DYNAMICS
$2,287,500Alexander Benjamin Barnes · Washington University · DP2 · FY2015 · GM
Clinical trials to prevent Alzheimer's Disease in Down Syndrome
$2,287,306Michael S Rafii · University Of Southern California · R33 · FY2023 · AG